| 08:15 | Visual and Vital Prognosis of Intraocular Lymphoma at Hokkaido University Hospital, Japan | WATANABE D, KASE S, SUZUKI K, NAMBA K, IWATA D, OGINO Y, ISHIDA S | ||
| 08:20 | Interleukin-6 receptor (IL-6R) signaling inhibition with satralizumab in thyroid eye disease (TED): phase 3 SatraGO-1 and SatraGO-2 trial design | CORONEL M, EZRA D, COLLINS A, STAN M, HASKOVA Z, KUENZEL T, TRIYATNI M, IDOWU O | ||
| 08:25 | The Effectiveness of Wide Field OCTA in the Diagnosis and Monitoring of Retinal Vessel and Choroidal Inflammation | HARRIGILL M, NGUYEN M, NOORI J | ||
| 08:30 | Novel OCT Finding of Retinal Vasculitis Associated with Multiple Sclerosis | ALBLOUSHI A F | ||
| 08:35 | Pediatric Pars Planitis: Clinical characteristics and the role of RNFL thickness on OCT in disease monitoring | ABU AL-HALAWA D, AMER R | ||
| 08:40 | Sensitivity and specificity of ICGA and BAF in patients with active primary choriocapillaritis. | DÍAZ DUEÑAS A, SARMIENTO FORERO D M, RUíZ CRUZ M, CONCHA DEL RíO L E | ||
| 08:45 | End of Session | |||